Zscaler, Inc. vs NVIDIA Corporation — Stock Comparison
Q·Score Breakdown
6.9
Hold
Overall
9.1
Strong Buy
Quality
Health
Growth
Valuation
Sentiment
ZS
Analysts see 75% upside to $229.45 consensus target.
⚠ currently unprofitable (-2% margin).
NVDA
Clean balance sheet with low leverage (0.1× debt-to-equity).
Analyst Consensus
BUY
Target $229.45 (+75.1%)
45 analysts
BUY
Target $269.17 (+34.3%)
57 analysts
Fundamentals
ZS
NVDA
—
Trailing P/E
40.9×
28.6×
Forward P/E
17.8×
-2.3%
Profit Margin
55.6%
76.6%
Gross Margin
71.1%
-3.6%
ROE
101.5%
25.9%
Revenue Growth
73.2%
—
Earnings Growth
95.6%
1.11
Beta
2.33
—
Price / Book
—
$21.1B
Market Cap
$4.87T
$115 – $337
52-Week Range
$111 – $217
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.